rs3751889

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 8P and 16B. PVS1BP6_Very_StrongBA1

The ENST00000711482.1(CACNA1H):​c.6121+2T>C variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0274 in 1,427,114 control chromosomes in the GnomAD database, including 1,083 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.053 ( 435 hom., cov: 34)
Exomes 𝑓: 0.024 ( 648 hom. )

Consequence

CACNA1H
ENST00000711482.1 splice_donor, intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.98

Publications

11 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 9.4, offset of 14, new splice context is: ccgGTgagg. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
BP6
Variant 16-1220055-T-C is Benign according to our data. Variant chr16-1220055-T-C is described in ClinVar as Benign. ClinVar VariationId is 96014.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.128 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000711482.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.6123T>Cp.Gly2041Gly
synonymous
Exon 35 of 35NP_066921.2O95180-1
CACNA1H
NM_001005407.2
c.6105T>Cp.Gly2035Gly
synonymous
Exon 34 of 34NP_001005407.1O95180-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.6123T>Cp.Gly2041Gly
synonymous
Exon 35 of 35ENSP00000334198.7O95180-1
CACNA1H
ENST00000569107.6
TSL:1
c.6138T>Cp.Gly2046Gly
synonymous
Exon 34 of 34ENSP00000454990.2H3BNT0
CACNA1H
ENST00000711493.1
c.6108T>Cp.Gly2036Gly
synonymous
Exon 34 of 34ENSP00000518778.1A0AAA9YHG8

Frequencies

GnomAD3 genomes
AF:
0.0531
AC:
8074
AN:
152062
Hom.:
426
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.130
Gnomad AMI
AF:
0.00881
Gnomad AMR
AF:
0.0354
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.0965
Gnomad SAS
AF:
0.0424
Gnomad FIN
AF:
0.00791
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0182
Gnomad OTH
AF:
0.0440
GnomAD2 exomes
AF:
0.0325
AC:
2972
AN:
91576
AF XY:
0.0294
show subpopulations
Gnomad AFR exome
AF:
0.133
Gnomad AMR exome
AF:
0.0462
Gnomad ASJ exome
AF:
0.00684
Gnomad EAS exome
AF:
0.0769
Gnomad FIN exome
AF:
0.00933
Gnomad NFE exome
AF:
0.0182
Gnomad OTH exome
AF:
0.0342
GnomAD4 exome
AF:
0.0243
AC:
30971
AN:
1274936
Hom.:
648
Cov.:
30
AF XY:
0.0241
AC XY:
14889
AN XY:
618304
show subpopulations
African (AFR)
AF:
0.138
AC:
3500
AN:
25370
American (AMR)
AF:
0.0438
AC:
861
AN:
19658
Ashkenazi Jewish (ASJ)
AF:
0.00623
AC:
111
AN:
17826
East Asian (EAS)
AF:
0.0777
AC:
2405
AN:
30938
South Asian (SAS)
AF:
0.0368
AC:
1989
AN:
54086
European-Finnish (FIN)
AF:
0.0101
AC:
465
AN:
45862
Middle Eastern (MID)
AF:
0.0240
AC:
123
AN:
5116
European-Non Finnish (NFE)
AF:
0.0194
AC:
19821
AN:
1023560
Other (OTH)
AF:
0.0323
AC:
1696
AN:
52520
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1839
3678
5518
7357
9196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
926
1852
2778
3704
4630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0533
AC:
8106
AN:
152178
Hom.:
435
Cov.:
34
AF XY:
0.0523
AC XY:
3890
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.131
AC:
5419
AN:
41488
American (AMR)
AF:
0.0353
AC:
541
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3470
East Asian (EAS)
AF:
0.0969
AC:
501
AN:
5170
South Asian (SAS)
AF:
0.0422
AC:
204
AN:
4830
European-Finnish (FIN)
AF:
0.00791
AC:
84
AN:
10614
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0182
AC:
1236
AN:
67986
Other (OTH)
AF:
0.0431
AC:
91
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
380
760
1139
1519
1899
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0271
Hom.:
153
Bravo
AF:
0.0583
Asia WGS
AF:
0.0760
AC:
264
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.032
DANN
Benign
0.44
PhyloP100
-4.0
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3751889; hg19: chr16-1270055; COSMIC: COSV52355369; COSMIC: COSV52355369; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.